Preimplantation genetic screening: what is the clinical efficiency?
In the current practice of in vitro fertilization (IVF), preimplantation genetic screening (PGS) is increasingly used to select embryos for transfer. This strategy is designed to maximize the probability of embryo implantation by eliminating embryos with low implantation potential from the cohort. However, PGS is inherently imperfect. Errors may occur during the genetic analysis of the small amount of DNA collected. More importantly, mitotic mosaicism, whose precise incidence in the preimplantation embryo is not known, may lead to sampling errors due to the intentionally limited collection of cells in the trophectoderm biopsy.
Source: fertstert.org
Preimplantation genetic screening: what is the clinical efficiency?
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment